Papers

Peer-reviewed International journal
May 16, 2019

Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.

Nature communications
  • Mizuo Ando
  • Yuki Saito
  • Guorong Xu
  • Nam Q Bui
  • Kate Medetgul-Ernar
  • Minya Pu
  • Kathleen Fisch
  • Shuling Ren
  • Akihiro Sakai
  • Takahito Fukusumi
  • Chao Liu
  • Sunny Haft
  • John Pang
  • Adam Mark
  • Daria A Gaykalova
  • Theresa Guo
  • Alexander V Favorov
  • Srinivasan Yegnasubramanian
  • Elana J Fertig
  • Patrick Ha
  • Pablo Tamayo
  • Tatsuya Yamasoba
  • Trey Ideker
  • Karen Messer
  • Joseph A Califano
  • Display all

Volume
10
Number
1
First page
2188
Last page
2188
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1038/s41467-019-09937-w

Although promoter-associated CpG islands have been established as targets of DNA methylation changes in cancer, previous studies suggest that epigenetic dysregulation outside the promoter region may be more closely associated with transcriptional changes. Here we examine DNA methylation, chromatin marks, and transcriptional alterations to define the relationship between transcriptional modulation and spatial changes in chromatin structure. Using human papillomavirus-related oropharyngeal carcinoma as a model, we show aberrant enrichment of repressive H3K9me3 at the transcriptional start site (TSS) with methylation-associated, tumor-specific gene silencing. Further analysis identifies a hypermethylated subtype which shows a functional convergence on MYC targets and association with CREBBP/EP300 mutation. The tumor-specific shift to transcriptional repression associated with DNA methylation at TSSs was confirmed in multiple tumor types. Our data may show a common underlying epigenetic dysregulation in cancer associated with broad enrichment of repressive chromatin marks and aberrant DNA hypermethylation at TSSs in combination with MYC network activation.

Link information
DOI
https://doi.org/10.1038/s41467-019-09937-w
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31097695
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522544
URL
http://www.scopus.com/inward/record.url?eid=2-s2.0-85065779800&partnerID=MN8TOARS
ID information
  • DOI : 10.1038/s41467-019-09937-w
  • ORCID - Put Code : 70534895
  • Pubmed ID : 31097695
  • Pubmed Central ID : PMC6522544
  • SCOPUS ID : 85065779800

Export
BibTeX RIS